Transcatheter Occlusion of Azygos/Hemiazygos Vein in Patients with Systemic Venous Collateral Development after the Bidirectional Glenn Procedure

Lu, Minjie; Wu, Wenhui; Zhang, Gejun; Zhao, Tianming; Xu, Zhiwei; Zheng, Hong; Xiangli, Wei; Tian, Lu; Liu, Sheng; Jiang, Suping; Zhao, Shihua

doi:10.1159/000362157

Cited by 2 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…McElhinney et al 3 reported study of 55patients with median age of 1.4 years with collateral channels after BDG and successful coil embolization and increase in SaO 2 of 16%.Lu M. et al 6 reported on cohort study of nine patients with progressive cyanosis after BDG and median age of 9 years with successful trans catheter occlusion of the azygos/hemiazygosvein. Total 3 hemiazygos veins and 7 azygos veins occluded.…”

Section: Discussionmentioning

confidence: 99%

Trans catheter device closure of a large azygos vein in adult patient with systemic venous collateral development after the bidirectional Glenn shunt

Khajali

Firouzi

Pashapour

et al. 2021

J Cardiovasc Thorac Res

View full text Add to dashboard Cite

Superior cavopulmonary anastomosis is a type of palliative cardiac surgeries that usually done in children with cyanotic and complex congenital heart disease who have single ventricle profile. BDG shunt is staged palliation procedure for single ventricle patients who are candidates for total cavopulmonary connection (TCPC). Sometimes the surgeon misses ligating or intentionally leaves the azygos vein as a fenestration or emergency exit. This allows an abnormal flow from the superior vena cava (SVC into azygos vein). These patients can present progressive desaturation, chest tightness, progressive dyspnea, edema and shortness of breath. Therapeutic options include observation, surgical ligation and trans catheter closure. Because of high risks and extra traumas of surgery and greater chance for difficulties and the feasibility of trans catheter therapy, it is done in some centers as a method of choice.

show abstract

Section: Discussionmentioning

confidence: 99%

Trans catheter device closure of a large azygos vein in adult patient with systemic venous collateral development after the bidirectional Glenn shunt

Khajali

Firouzi

Pashapour

et al. 2021

J Cardiovasc Thorac Res

View full text Add to dashboard Cite

show abstract

“…Veno-venous collaterals frequently occur after partial cavo-pulmonary connection (PCPC) for surgical palliation of patients with functionally univentricular hearts (UVH) ( 1 ), with a reported incidence that varies from 17% to as high as 31% ( 2 ). Veno-venous collaterals decrease the arterial oxygen saturation in such patients and may worsen the outcome ( 3 ).…”

Section: Introductionmentioning

confidence: 99%

Catheter interventional closure of veno-venous collaterals in cyanotic patients after partial cavopulmonary shunts in pediatric patients: clinical practice review

Abdelaziz¹,

Tanase²,

Ewert³

et al. 2023

Cardiovasc Diagn Ther

View full text Add to dashboard Cite

The development of veno-venous collaterals is an important and treatable cause of cyanosis in patients who had undergone partial cavo-pulmonary connection (PCPC) operations. Nevertheless, the literature on this complicated therapeutic option is sparse. Patients can present cyanosis either immediately after the operation (<30 days), which delays or hinders discharge from the intensive care unit or cyanosis may occur late: (>30 days and/or in another hospital admission), after the operation. Hence, transcatheter closure of veno-venous collaterals is the treatment of choice. Four patients were selected who showed cyanosis at variable durations after PCPC; the morphology of the collaterals and their hemodynamic effect was described and the strategy for closure of such abnormal vessels is suggested. Veno-venous collaterals described in our series were seen originating mainly or mostly from innominate vein angles. The drainage sites were either above the diaphragm into a cardiac structure: the coronary sinus (CS) and/or atria; or below the diaphragm into the inferior vena cava (IVC) or hepatic veins through the paravertebral venous system and/or the azygous system. It is stated in the literature that several types of devices and coils can be used to close the collaterals such as the Amplatzer vascular plugs (AVPs), Amplatzer duct occluder II (ADOII), non-detachable and detachable coils. In this clinical review, the technical details that determine device type and size are explained. The recent generations of hydrogel-coated coils were also used in this series of patients to close the difficult types of collaterals with better results. All described vessels were closed successfully, without any complications. The patients had a significant rise in their transcutaneous oxygen saturations and hence, a clear clinical benefit.

show abstract

Transcatheter Occlusion of Azygos/Hemiazygos Vein in Patients with Systemic Venous Collateral Development after the Bidirectional Glenn Procedure

Cited by 2 publications

References 18 publications

Trans catheter device closure of a large azygos vein in adult patient with systemic venous collateral development after the bidirectional Glenn shunt

Trans catheter device closure of a large azygos vein in adult patient with systemic venous collateral development after the bidirectional Glenn shunt

Catheter interventional closure of veno-venous collaterals in cyanotic patients after partial cavopulmonary shunts in pediatric patients: clinical practice review

Contact Info

Product

Resources

About